Gene · 8661
Papers4,269
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,269
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SUZ domain-containing proteins have multiple effects on nonsense-mediated decay target transcripts. | J Biol Chem | 2023 | 37507022 | PubTator, text mining | PubMed |
| Leishmania infantum Axenic Amastigotes Induce Human Neutrophil Extracellular Traps and Resist NET-Mediated Killing. | Trop Med Infect Dis | 2023 | 37505632 | PubTator, text mining | PubMed |
| Characterization of epitranscriptome reader proteins experimentally and in silico: Current knowledge and future perspectives beyond the YTH domain. | Comput Struct Biotechnol J | 2023 | 37501707 | PubTator, text mining | PubMed |
| Nascent mitochondrial proteins initiate the localized condensation of cytosolic protein aggregates on the mitochondrial surface. | Proc Natl Acad Sci U S A | 2023 | 37494397 | PubTator, text mining | PubMed |
| mTOR inhibition reprograms cellular proteostasis by regulating eIF3D-mediated selective mRNA translation and promotes cell phenotype switching. | Cell Rep | 2023 | 37494188 | PubTator, text mining | PubMed |
| Multilevel regulation of N6-methyladenosine RNA modifications: Implications in tumorigenesis and therapeutic opportunities. | Genes Dis | 2023 | 37492716 | PubTator, text mining | PubMed |
| N6-methyladenosine RNA modification: an emerging molecule in type 2 diabetes metabolism. | Front Endocrinol (Lausanne) | 2023 | 37484964 | PubTator, text mining | PubMed |
| Characteristics and molecular mechanism of drug-tolerant cells in cancer: a review. | Front Oncol | 2023 | 37483492 | PubTator, text mining | PubMed |
| Piscine Vitamin D Receptors Vdra/Vdrb in the Absence of Vitamin D Are Utilized by Grass Carp Reovirus for Promoting Viral Replication. | Microbiol Spectr | 2023 | 37466438 | PubTator, text mining | PubMed |
| SINEUPs to boost translation. | Mol Ther Nucleic Acids | 2023 | 37449044 | PubTator, text mining | PubMed |
| The Role of mTORC1 Pathway and Autophagy in Resistance to Platinum-Based Chemotherapeutics. | Int J Mol Sci | 2023 | 37445831 | PubTator, text mining | PubMed |
| Role of N6-methyladenosine RNA modification in gastric cancer. | Cell Death Discov | 2023 | 37443100 | PubTator, text mining | PubMed |
| Levels and clinical significance of the m6A methyltransferase METTL14 in patients with coronary heart disease. | Front Cardiovasc Med | 2023 | 37441706 | PubTator, text mining | PubMed |
| METTL3-mediated m6A modification of LINC00839 maintains glioma stem cells and radiation resistance by activating Wnt/β-catenin signaling. | Cell Death Dis | 2023 | 37438359 | PubTator, text mining | PubMed |
| Crosstalk between m6A and coding/non-coding RNA in cancer and detection methods of m6A modification residues. | Aging (Albany NY) | 2023 | 37437245 | PubTator, text mining | PubMed |
| Comprehensive analysis of m6A regulators characterized by the immune microenvironment in Duchenne muscular dystrophy. | J Transl Med | 2023 | 37434186 | PubTator, text mining | PubMed |
| Translational regulation by uORFs and start codon selection stringency. | Genes Dev | 2023 | 37433636 | PubTator, text mining | PubMed |
| Characterization of the alternative splicing landscape in lung adenocarcinoma reveals novel prognosis signature associated with B cells. | PLoS One | 2023 | 37432957 | PubTator, text mining | PubMed |
| B cell receptor-induced protein dynamics and the emerging role of SUMOylation revealed by proximity proteomics. | J Cell Sci | 2023 | 37417469 | PubTator, text mining | PubMed |
| ZCCHC3 is a stress granule zinc knuckle protein that strongly suppresses LINE-1 retrotransposition. | PLoS Genet | 2023 | 37405998 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8661/papers?page=15